150 related articles for article (PubMed ID: 15479841)
1. Functional correlation of P-glycoprotein expression and genotype with expression of the human immunodeficiency virus type 1 coreceptor CXCR4.
Owen A; Chandler B; Bray PG; Ward SA; Hart CA; Back DJ; Khoo SH
J Virol; 2004 Nov; 78(21):12022-9. PubMed ID: 15479841
[TBL] [Abstract][Full Text] [Related]
2. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 viral envelope glycoprotein gp120 triggers an inflammatory response in cultured rat astrocytes and regulates the functional expression of P-glycoprotein.
Ronaldson PT; Bendayan R
Mol Pharmacol; 2006 Sep; 70(3):1087-98. PubMed ID: 16790532
[TBL] [Abstract][Full Text] [Related]
4. HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.
Wilkin TJ; Su Z; Kuritzkes DR; Hughes M; Flexner C; Gross R; Coakley E; Greaves W; Godfrey C; Skolnik PR; Timpone J; Rodriguez B; Gulick RM
Clin Infect Dis; 2007 Feb; 44(4):591-5. PubMed ID: 17243065
[TBL] [Abstract][Full Text] [Related]
5. Genotypic coreceptor analysis.
Sierra S; Kaiser R; Thielen A; Lengauer T
Eur J Med Res; 2007 Oct; 12(9):453-62. PubMed ID: 17933727
[TBL] [Abstract][Full Text] [Related]
6. CXCR4 and CCR5 regulation and expression patterns on T- and monocyte-macrophage cell lineages: implications for susceptibility to infection by HIV-1.
Joly M; Pinto JM
Math Biosci; 2005 May; 195(1):92-126. PubMed ID: 15893340
[TBL] [Abstract][Full Text] [Related]
7. Gene silencing of HIV chemokine receptors using ribozymes and single-stranded antisense RNA.
Qureshi A; Zheng R; Parlett T; Shi X; Balaraman P; Cheloufi S; Murphy B; Guntermann C; Eagles P
Biochem J; 2006 Mar; 394(Pt 2):511-8. PubMed ID: 16293105
[TBL] [Abstract][Full Text] [Related]
8. Determination of HIV-1 coreceptor tropism in clinical practise.
Foeglein A; Walter H
Eur J Med Res; 2007 Oct; 12(9):473-82. PubMed ID: 17933729
[TBL] [Abstract][Full Text] [Related]
9. Rapid and simple phenotypic assay for drug susceptibility of human immunodeficiency virus type 1 using CCR5-expressing HeLa/CD4(+) cell clone 1-10 (MAGIC-5).
Hachiya A; Aizawa-Matsuoka S; Tanaka M; Takahashi Y; Ida S; Gatanaga H; Hirabayashi Y; Kojima A; Tatsumi M; Oka S
Antimicrob Agents Chemother; 2001 Feb; 45(2):495-501. PubMed ID: 11158746
[TBL] [Abstract][Full Text] [Related]
10. Replicative fitness of CCR5-using and CXCR4-using human immunodeficiency virus type 1 biological clones.
Ariën KK; Gali Y; El-Abdellati A; Heyndrickx L; Janssens W; Vanham G
Virology; 2006 Mar; 347(1):65-74. PubMed ID: 16386774
[TBL] [Abstract][Full Text] [Related]
11. Effect of protease inhibitor-containing regimens on lymphocyte multidrug resistance transporter expression.
Ford J; Meaden ER; Hoggard PG; Dalton M; Newton P; Williams I; Khoo SH; Back DJ
J Antimicrob Chemother; 2003 Sep; 52(3):354-8. PubMed ID: 12917239
[TBL] [Abstract][Full Text] [Related]
12. Regulation of CCR5 and CXCR4 expression by type 1 and type 2 cytokines: CCR5 expression is downregulated by IL-10 in CD4-positive lymphocytes.
Patterson BK; Czerniewski M; Andersson J; Sullivan Y; Su F; Jiyamapa D; Burki Z; Landay A
Clin Immunol; 1999 Jun; 91(3):254-62. PubMed ID: 10370370
[TBL] [Abstract][Full Text] [Related]
13. Tropism switch in patients infected with HIV-1 and its clinical implications for the treatment with CCR5-receptor inhibitors.
Arastéh K; Stocker H
Eur J Med Res; 2007 Oct; 12(9):397-402. PubMed ID: 17933720
[TBL] [Abstract][Full Text] [Related]
14. Generation and properties of a human immunodeficiency virus type 1 isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D).
Marozsan AJ; Kuhmann SE; Morgan T; Herrera C; Rivera-Troche E; Xu S; Baroudy BM; Strizki J; Moore JP
Virology; 2005 Jul; 338(1):182-99. PubMed ID: 15935415
[TBL] [Abstract][Full Text] [Related]
15. Molecular and clinical epidemiology of CXCR4-using HIV-1 in a large population of antiretroviral-naive individuals.
Brumme ZL; Goodrich J; Mayer HB; Brumme CJ; Henrick BM; Wynhoven B; Asselin JJ; Cheung PK; Hogg RS; Montaner JS; Harrigan PR
J Infect Dis; 2005 Aug; 192(3):466-74. PubMed ID: 15995960
[TBL] [Abstract][Full Text] [Related]
16. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.
Waters L; Mandalia S; Randell P; Wildfire A; Gazzard B; Moyle G
Clin Infect Dis; 2008 May; 46(10):1617-23. PubMed ID: 18419499
[TBL] [Abstract][Full Text] [Related]
17. Interferon downregulates CXCR4 (fusin) gene expression in peripheral blood mononuclear cells.
Shirazi Y; Pitha PM
J Hum Virol; 1998; 1(2):69-76. PubMed ID: 10195234
[TBL] [Abstract][Full Text] [Related]
18. Presence of CXCR4-using HIV-1 in patients with recently diagnosed infection: correlates and evidence for transmission.
Chalmet K; Dauwe K; Foquet L; Baatz F; Seguin-Devaux C; Van Der Gucht B; Vogelaers D; Vandekerckhove L; Plum J; Verhofstede C
J Infect Dis; 2012 Jan; 205(2):174-84. PubMed ID: 22147802
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis induced in synchronized human immunodeficiency virus type 1-infected primary peripheral blood mononuclear cells is detected after the peak of CD4+ T-lymphocyte loss and is dependent on the tropism of the gp120 envelope glycoprotein.
Lawson VA; Silburn KA; Gorry PR; Paukovic G; Purcell DF; Greenway AL; McPhee DA
Virology; 2004 Sep; 327(1):70-82. PubMed ID: 15327899
[TBL] [Abstract][Full Text] [Related]
20. Flying in the face of resistance: antiviral-independent benefit of HIV protease inhibitors on T-cell survival.
Vlahakis SR; Bren GD; Algeciras-Schimnich A; Trushin SA; Schnepple DJ; Badley AD
Clin Pharmacol Ther; 2007 Sep; 82(3):294-9. PubMed ID: 17361127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]